SEO Title
Blade Aims To Dominate Organ Transport Market in U.S.
Subtitle
Blade said it will merge its MediMobility business with Trinity Air Medical, which it has signed an agreement to acquire.
Subject Area
Teaser Text
Blade said it will merge its MediMobility business with Trinity Air Medical, which it has signed an agreement to acquire.
Content Body

Blade Air Mobility has entered into a definitive agreement to acquire Trinity Air Medical, a nationwide, multi-modal organ logistics and transportation company. The transaction is expected to close this week for a purchase price of $23 million. Blade said it expects the combination of its own MediMobility business and Trinity to become the largest dedicated organ transport arranger in the U.S.


MediMobility is growing at a rate of 60 percent per year while Trinity is profitable and generated revenues of $16 million last year working with transplant centers and organ procurement organizations in 16 U.S. states. Blade said the combined company will rapidly transition to the use of drones and eVTOLs.


“Trinity’s end-to-end services integrate air missions with ground transport,” said Rob Wiesenthal, Blade’s CEO. “Given the existence of landing pads at most hospitals today, we have the ability to immediately replace Trinity’s ambulances with helicopters on certain hospital-to-hospital missions, while preparing for a transition to both existing ‘last-mile’ cargo drones, as well as electric vertical aircraft, as soon as they become available.”


Trinity CEO Seth Bacon will run the combined company. “Blade’s scale in air transport missions coupled with their aerospace manufacturer relationships position us to continue expanding share in today’s growing market," Bacon said, "while laying the groundwork to deploy forthcoming drone and electric vertical aircraft technology, which will reduce transit times and improve patient outcomes.”

Expert Opinion
False
Ads Enabled
True
Used in Print
False
Writer(s) - Credited
Publication Date (intermediate)
AIN Publication Date
----------------------------